Connect with us

Press Release

China Medical System (00867) Released its 2024 Interim Results: Steady Increase in Revenue and Profit Compared with 2H 2023

Published

on

CMS enters the “New Product Era” driven by exclusive and innovative products, with exclusive and innovative drugs revenue accounts for over 56%.

 

SHENZHEN, CHINA – On August 15, 2024, China Medical System Holdings Limited (“CMS” or the “Company”) released its 2024 interim results announcement, with a steady increase in overall revenue and profit for the period compared to the second half (2H) of 2023. In the first half (1H) of 2024, the Company recorded a turnover of RMB3,611.1 million, representing a decrease of 21.7% compared with 1H 2023, an increase of 6.1% compared with 2H 2023. In the case that all medicines were directly sold by the Company, the turnover was RMB4,287.5 million, representing a decrease of 22.6% compared with 1H 2023, an increase of 8.9% compared with 2H 2023; Among which, the total revenue of non-National VBP exclusive products and innovative products was RMB2,404.7 million, accounting for 56.1% of CMS’s revenue in the case that all medicines were directly sold by the Company. Profit for the period was RMB903.4 million, representing a decrease of 52.8% compared with 1H 2023, a substantial increase of 92.8% compared with 2H 2023.

 

The year 2024, not only marks the first year of the commercialization of CMS’s innovative products, but also a crucial point for the release of National Volume Based Procurement (“National VBP”) impact on its financial performance. Deanxit entered the seventh batch of National VBP in November 2022, Plendil and Ursofalk entered the eighth batch of National VBP in July 2023, and none of the three original drugs were selected, which had a negative impact on the Company’s business performance. In 1H 2024, the Company’s overall performance showed a growth trend compared with 2H 2023, indicating that CMS has basically digested the impact of National VBP and successfully entered the “New Product Era” where non-national VBP exclusive products and innovative products drive its growth.

 

With the approval for marketing of LUMEBLUE (Methylthioninium Chloride Enteric-coated Sustained-release Tablets) in June and METOJECT (Methotrexate Injection)’s additional indication of active rheumatoid arthritis (RA) in adults in July this year, CMS’s innovative drug portfolio in the commercialization stage has expanded into 5 products (including 6 indications); simultaneously with a rich and differentiated innovative pipeline reserve. Gathering the power of innovation and riding the momentum of development, CMS is comprehensively shaping new drivers for development with a healthier product structure, further opening up a new cycle of quality development.

 

The “Collaborative and In-house” dual-engine R&D model drives the simultaneous improvement in quantity and quality of the pipeline, accelerating the transformation of innovative biotechnology

 

A profound innovative drug R&D pipeline is an important driving force for the long-term development of CMS. The Company adheres to the purpose of innovation for meeting the unmet clinical needs and solving the difficulties of patient medication, and promotes innovation development through a two-wheel drive of “Collaborative R&D and In-house R&D”, continuously deploying FIC (first-in-class) and BIC (best-in-class) innovative products, and enhancing the capabilities and efficiency of research and clinical development to achieve a rapid transformation of scientific outcomes into social and commercial values.

 

As of now, CMS’s innovative product portfolio approved for marketing in China has been expanded into 5 products (including 6 indications), among which, 4 innovative drugs (VALTOCO, ILUMETRI, METOJECT – psoriasis indication, VELPHORO) have been included in the National Reimbursement Drug List (NRDL) and entered large-scale clinical application; also, CMS newly added LUMEBLUE and METOJECT (RA), for being approved for marketing in China recently.

 

CMS has also steadily advanced the clinical development of innovative products. Currently, Desidustat Tablets is under NDA review in China; Also, a total of about 10 projects have been prepared/launched for their registrational clinical trials, mainly randomized controlled trials (RCT).

 

At the same time, the Company had continued to strengthen basic research and independent innovation capabilities, and successfully promoted more than 10 in-house R&D projects, among which, three innovative drugs (VEGFA/ANG2 Tetravalent Bispecific Antibody, Highly Selective TYK2 Inhibitor CMS-D001 Tablets, and GnRH Receptor Antagonist CMS-D002 Capsules) have entered the clinical development stage.

 

In addition, the Company’s innovative pipeline has continued to expand. CMS Skinhealth collaborated with Incyte once again, and has obtained exclusive license to research, develop, register and commercialize povorcitinib, a selective oral small-molecule JAK1 inhibitor, in countries/territories including Mainland China, Hong Kong, Macau, Taiwan Region and 11 Southeast Asian countries. This further enriched the product portfolio of CMS Skinhealth in the treatment of vitiligo and other immune-mediated dermatology diseases.

 

Subsequently, CMS will continue to produce innovative products with higher efficiency and more controllable costs every year, accelerating the release of innovative value and embracing quality and sustainable performance growth through a healthy product structure dominated by non-National VBP exclusive products and innovative products.

 

Successful commercialization system releases the clinical value of innovative products in an efficient and collaborative manner

 

After 32 years of deep cultivation in specialty therapeutical fields, successful commercialization capability is one of CMS’s core competitiveness. By continuously reinforcing and integrating its commercialization platform, it has achieved in-depth development of its three major business segments including cardio-cerebrovascular/gastroenterology, dermatology, and ophthalmology, and expanded its boundaries in related fields. Additionally, the Company established a highly qualified, professional promotion team with strong execution, as well as extensive channel and resource coverage, which has laid a solid foundation for the rapid market entry and brand building of its innovative products.

 

Four innovative drugs of CMS have entered large-scale clinical applications, covering various disease fields such as central nervous system, dermatology, nephrology, and gastroenterology, and developed synergistically with the existing marketed products in promotion team and channels. Meanwhile, leveraging on the opportunity of being included in the NRDL, CMS is advancing hospital development, brand building, real world studies and medically-driven academic promotion. CMS is improving patients’ accessibility to innovative drugs with the help of patient aid and disease knowledge popularization programs, promoting the release of products’ clinical value.

 

The Dermatology and Medical Aesthetic Business “CMS Skinhealth” regards dermatology prescription products as its core, and extends to light medical aesthetic products and dermatology-grade skincare products, continuously improving the construction of a full life-cycle skin-health management platform covering dermatological treatment, skincare, and medical aesthetics through internal development and external collaboration. In terms of clinical development of dermatology prescription drugs, CMS has completed the Pivotal Real World Study for ruxolibinib cream in vitiligo, and is advancing the registration application process in Mainland China. At the same time, it has continuously complemented the regenerative light medical aesthetic portfolio, among which the China’s medical device registration application of the Poly-L-lactic Acid Microparticle Filler Injection has been accepted by the NMPA during the Reporting Period; and the Company has newly obtained exclusive licenses of three regenerative light medical aesthetic products (Polycaprolactone Microsphere Gel for Injection, Calcium Hydroxylapatite Microsphere Gel for Injection, and Decellularized Extracellular Matrix Implant), which are currently under the registrational clinical trial stage in China.

 

The results announcement shows that, as of the end of June, the promotion network of CMS has covered over 55,000 hospitals and medical institutions, and approximately 280 thousand retail pharmacies in China.

 

Leveraging the accumulated advantages in cardio-cerebrovascular, gastroenterology, central nervous system, nephrology, ophthalmology, dermatology and other specialty therapeutical fields, CMS steadily releases the scale effect of its specialty businesses, and builds high competition barriers, creating broad commercial potential for its innovative products and exclusive products.

 

Drawing up the internationalization layout to gather momentum for the incremental market

 

Integrating the advantageous resources of the Company, its Southeast Asia business “Rxilient Health”, shares and expands the successful experience of CMS gained from the China market, as well as global quality products and innovative technological resources, into the Southeast Asia market. This accelerates the improvement of the platform integrating “R&D, manufacture, and commercialization” of the Southeast Asia business, empowering Chinese and global pharmaceutical companies to implement the “overseas development” strategy, and also opening up a larger space for incremental development opportunities for CMS.

 

As of the end of June, Rxilient Health has established a competitive product portfolio with more than ten differentiated products, covering therapeutic areas such as oncology, central nervous system, autoimmune, dermatology, and ophthalmology, etc. Rxilient Health is accelerating the relevant work on the market registration processes in Southeast Asian countries for innovative pipeline products, such as ruxolitinib cream, Methylthioninium Chloride Enteric-coated Sustained-release Tablets, and Diazepam Nasal Spray, etc. Furthermore, Rxilient Health collaborated with Junshi Biosciences to promote the registration process of toripalimab (anti-PD-1 monoclonal antibody) in multiple countries in Southeast Asia, aiming to benefit local cancer patients as soon as possible.

 

In December last year, the Company and Rxilient Health joined hands with Pharmaron and other partners to complete the purchase of the Singapore manufacturing plant. This year, all relevant parties have been orderly advancing a series of work for the Singapore manufacturing plant, including equipment testing, quality verification, and production quality system certification, etc., so as to accelerate the CDMO business development, and to optimize the Company’s overseas supply chain and manufacturing capabilities. The business layout will further facilitate more inter-industry cooperation between CMS and global partners in the future, thus jointly building a win-win medical innovation ecosystem with mutual benefits.

 

Conclusion

Since its establishment in 1992, CMS has followed the development pattern of the industry and has promoted three significant strategic transformations successfully with a forward-looking vision. The Company started as an agent of imported original drugs, gradually developed to control the rights of original/exclusive products, and then achieved a comprehensive innovative transformation. Each step of the transformation is in sync with the industry development trends. CMS steadily aims towards the ultimate goal, and constantly builds up its strength and resilience to persist through the industry development cycle. With the gradual release of the impact of national VBP on its financial performance, CMS has been transforming into a brand-new company. While embracing the innovation achievements in each stage, CMS is fully prepared for a sustainable and healthier development in the future.

 

About CMS

CMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs.

 

CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients.

 

CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development of its advantageous specialty fields and expand business boundaries. While strengthening the competitiveness of the cardio-cerebrovascular/gastroenterology business, CMS independently operates its dermatology and medical aesthetics business, and ophthalmology business, aiming to gain leading positions in specialty therapeutic fields, whilst enhancing the scale and efficiency. At the same time, CMS has expanded its business territory to the Southeast Asian market, striving to become a “bridgehead” for global pharmaceutical companies to enter the Southeast Asian market, further escorting the sustainable and healthy development of the Group.

 

CMS Disclaimer and Forward-Looking Statements

This press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert.

 

This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections.

 

 

Media Contact

Brand: China Medical System Holdings Ltd.

Contact: CMS Investor Relations

Email: ir@cms.net.cn

Website: https://web.cms.net.cn/en/home/

Source: China Medical System Holdings Ltd.

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

NWAM & Quant Insight reached a strategic cooperation to create new development opportunities and reshape the future of the quantitative market

Published

on

In today’s financial markets, data-driven intelligent analysis is rapidly becoming a powerful backing for investors. For New World Asset Management (NWAM), 2024 is destined to be a milestone year, as they have launched a forward-looking collaboration with London-based fintech pioneer Quant Insight. This is not only a technical integration, but also an art of interweaving market trends, data and analysis, allowing investors to stand at the forefront of the market, foresee the future and adjust their strategies.

In today’s financial markets, data-driven intelligent analysis is rapidly becoming a powerful backing for investors. For New World Asset Management (NWAM), 2024 is destined to be a milestone year, as they have launched a forward-looking collaboration with London-based fintech pioneer Quant Insight. This is not only a technical integration, but also an art of interweaving market trends, data and analysis, allowing investors to stand at the forefront of the market, foresee the future and adjust their strategies.

As a company headquartered in London, Quant Insight has provided in-depth market analysis support to hedge funds and asset management companies for many years. They do not simply provide data, but use big data and AI technology to extract truly valuable trends and risk signals from complex market noise. At the beginning of the cooperation, the Quant Insight team had a close dialogue with the NWAM technical team to clarify the goal – not just to bring data to the platform, but to reveal the market behavior and trends behind the data to investors.

“There is a pattern behind every market fluctuation,” said Quant Insight’s chief analyst. “Our task is to find those patterns hidden in the data.”  In this collaboration, engineers from NWAM and Quant Insight worked all night long, and technical experts from both sides discussed face-to-face and continuously polished the system integration plan. In these meetings, every subtle change in the market became the focus of discussion. In Q1 2024, they jointly launched the first market analysis tool based on the Quant Insight quantitative analysis system. NWAM users can now gain deep insights into market trends through real-time data on the platform.

However, simply analyzing the market is not enough. The real challenge lies in how to optimize investment strategies through these data. Quant Insight is well aware of this. Therefore, in Q2 2024, NWAM continued to work with the Quant Insight team to launch an optimization tool for investment strategies. This tool not only helps investors draw conclusions from quantitative analysis, but also provides them with a series of possible strategy adjustment options.  “We don’t want investors to just passively follow the market,” said NWAM’s CEO. “We want them to be proactive and use the most appropriate strategies to seize market opportunities.”

This is not just a simple theoretical analysis, every investor who uses quantitative tools will receive personalized strategy advice. Whether they are facing the volatility of global stock markets or the rapid rise and fall of cryptocurrencies, this set of tools can provide accurate market reaction advice.  From the initial negotiation to the implementation of the tool, the teams of both parties have always adhered to one goal: to empower global users with intelligent, data-driven investment decisions. When talking about the cooperation, the chief data scientist of Quant Insight said with deep emotion: “Working with NWAM, our technology no longer only serves top hedge funds, but also helps a wider range of global investors.”

The significance of this cooperation lies not only in technological breakthroughs, but also in the reshaping of future investor behavior. Through this cooperation, NWAM has expanded the vision of its global user base from traditional market analysis to a whole new level. Quant Insight’s AI quantitative analysis technology not only enhances the market insight of the NWAM platform, but also provides professional and amateur investors around the world with equally accurate market judgment tools.  In the future, this cooperation will continue to deepen. The NWAM team is already planning more system upgrades and tool development to expand Quant Insight’s quantitative analysis to more asset classes and markets. The cooperation between NWAM and Quant Insight is not just a combination of technologies, but also a bold imagination of the future of financial technology.  As the founder of Quant Insight said: “The market has never been so transparent, and we are making future investment decisions clearer.”  The changes brought about by this cooperation are no longer the exclusive domain of a few people, but will become an opportunity for every investor. Whether you are a hedge fund manager or a novice investor, the cooperation between NWAM and Quant Insight will ultimately provide you with tools to gain insight into the market and control the future.

Media Contact

Organization: New World Asset Management Ltd

Contact Person: Don Adam Perera

Website: https://newworldeco.com

Email: Send Email

Country: United States

Release Id: 19102418670

The post NWAM & Quant Insight reached a strategic cooperation to create new development opportunities and reshape the future of the quantitative market appeared on King Newswire. It is provided by a third-party content provider. King Newswire makes no warranties or representations in connection with it.

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

Linear Finance to Showcase Innovative DeFi Solutions at Chainlink SmartCon 2024

Published

on

Hong Kong, 19th Oct 2024 – Linear Finance is excited to announce its participation as a booth sponsor at the highly anticipated Chainlink SmartCon 2024, taking place on October 30-31. Positioned at Booth S5, centrally located on the conference floor, Linear Finance will present its latest advancements in decentralized finance (DeFi) to a global audience of blockchain leaders, innovators, and developers.

Recognized as one of the premier events in the blockchain and cryptocurrency space, SmartCon 2024 will gather thousands of attendees, offering Linear Finance an unparalleled opportunity to showcase its cutting-edge technologies, foster strategic partnerships, and contribute to the continued growth of the DeFi ecosystem.

Linear Finance will spotlight several key innovations, including its Perpetual DEX (Perp DEX), which offers seamless, frictionless trading with advanced features. The team will also introduce attendees to the latest upgrade of its multi-chain marketplace, featuring a dynamic discount function and the migration from BUSD to USDT. These enhancements reflect Linear’s ongoing commitment to making DeFi more accessible, functional, and user-friendly.

The event will also provide a platform to discuss Linear Finance’s broader roadmap, which includes expanded cross-chain interoperability, infrastructure developments for decentralized trading, and key upcoming partnerships. Attendees will have the unique opportunity to engage directly with the Linear team, explore the technology firsthand, and gain insights into the future of decentralized finance.

We are thrilled to be part of SmartCon 2024, where we can connect with the broader DeFi community,” said George, Business Development Manager at Linear Finance. “Linear Finance is at a pivotal moment, and we are eager to share our latest innovations and our vision for the future of DeFi.

Throughout the two-day event, the Linear Finance team will be available at Booth S5 to provide live demos and answer questions. For more information about Linear Finance’s presence at SmartCon 2024, or to schedule media interviews, please visit the website or contact the team.

Connect with Linear Finance: Discord || X || Medium 

About Linear Finance: 

Linear Finance is a decentralized finance platform that enables users to trade synthetic assets quickly, seamlessly, and cost-effectively. Offering a range of services such as staking and decentralized financial tools, Linear focuses on building a comprehensive DeFi ecosystem powered by a robust governance model that empowers community-driven decision-making.

Media Contact

Organization: Liner Finance

Contact Person: George [BDM at Linear Finance]

Website: https://linear.finance/

Email: Send Email

Country: Hong Kong S.A.R.

Release Id: 19102418663

The post Linear Finance to Showcase Innovative DeFi Solutions at Chainlink SmartCon 2024 appeared on King Newswire. It is provided by a third-party content provider. King Newswire makes no warranties or representations in connection with it.

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

YTL Foundation Builds BURN Ecology – BURN BANK: Opening a New Era of Blockchain Finance

Published

on

Against the backdrop of the increasing innovation of blockchain technology and the rapid rise of decentralized finance (DeFi), the YTL Foundation is keenly aware of the huge potential of the BURN token and is determined to vigorously promote the development of this project. The BURN token not only represents the transformation of digital finance in the future, but also carries a new vision of financial ecology. With the support of the YTL Foundation, the birth of the BURN Bank ecosystem will completely subvert the traditional financial model and lead the new trend of blockchain banking.

BURN Ecological Background: The Strategic Layout of the YTL Foundation

As the world’s leading innovative investment institution, YTL Foundation has been focusing on promoting the application and development of blockchain technology and digital assets. Through years of accumulation of technology, resources and capital, YTL Foundation is well aware that the financial market is undergoing a profound transformation – the transformation from the traditional centralized system to decentralized finance. Due to its unique technical architecture and unlimited application scenarios in the future, the BURN token has become the core project of the YTL Foundation’s key layout.

YTL Foundation is not only an investor in the BURN project, but also a strategic promoter of the BURN Bank ecosystem. By injecting huge amounts of capital and global resources, YTL Foundation is committed to building a comprehensive ecosystem that integrates diversified applications such as finance, lending, blockchain games (GameFi), and NFTs.

YTL Foundation’s capital volume and physical industry layout

YTL Foundation has a strong capital base, and its capital scale is among the best in the industry, covering a number of real industry sectors, including mainstream industries such as hotels, energy, and electricity. Taking the hotel industry as an example, the YTL Foundation has a number of high-end hotels, covering a wide range of choices from luxury resorts to business hotels, forming a tourism and accommodation network covering both domestic and foreign markets. These hotels not only provide excellent services to tourists, but also contribute to the development and prosperity of the region through integration with the local economy.

In the field of power and energy, the YTL Foundation also plays an important role. By investing in green energy projects, such as wind and solar, the Foundation is not only promoting the use of renewable energy, but also contributing to the sustainable development of society. The stable income and extensive influence of these real industries have enabled YTL Foundation to have solid capital strength, so as to better support the construction and development of the BURN Bank ecosystem.

The fundamental reason for developing the BURN Bank ecosystem is that YTL Foundation hopes to step into the blockchain industry and combine traditional financial services with digital assets to create a combination of digital and real effects. By combining the real industry with blockchain technology, the BURN Bank ecosystem not only provides users with financial services, but also creates more investment opportunities for users and promotes the overall development of the economy.

Eco-Tech Innovation: Leading the Future of Blockchain Banking

The technology architecture and operating model of the BURN Bank ecosystem is one of its biggest highlights. It not only innovatively applies blockchain technology, but also realizes the function of automatic fund entry and exit and real-time arrival in the form of smart contracts. The application of this technology makes the flow of funds in the BURN Bank ecosystem more efficient and secure, and greatly reduces the possibility of human intervention, thereby reducing the risk in financial operations.

Smart contracts automate execution to ensure that funds can be transferred from account to account quickly and securely, completely disrupting the lengthy processes and high fees of traditional banks. What’s more noteworthy is that BURN Bank has created a margin mechanism. The introduction of this mechanism provides a double guarantee for all participants – not only to ensure the smooth completion of transactions, but also to effectively prevent malicious behavior, and improve the trust of the entire ecosystem.

At the same time, the BURN ecosystem ensures that the security of users’ assets is protected to the greatest extent through multi-layer encryption technology and decentralized architecture. In the current blockchain market, although many projects claim to provide financial security, the technical architecture of the BURN ecosystem is undoubtedly at the forefront of the industry. Through real-time monitoring and smart contract execution, BURN Bank not only provides users with an efficient financial trading platform, but also sets a benchmark for the development of global blockchain banks.

Ecological security: Ensure the safety and stability of user assets

In the BURN ecosystem, safety is always one of the most important considerations. To this end, a margin storage mechanism has been established within the ecosystem to serve as a reserve for the return of principal. This not only effectively protects the rights and interests of both parties to the transaction, but also minimizes potential financial risks.

In addition, the BURN ecosystem uses BURN tokens as the circulating currency, and BURN tokens have a unique burning mechanism, which ensures the scarcity of tokens and the steady growth of prices by reducing the total amount of circulation in the market. In each transaction, a portion of the BURN tokens is automatically burned, further driving the long-term value growth of the BURN tokens. This continued reduction in supply means that the BURN token will gradually become a scarce resource, which in turn will attract more investor attention and participation. 

Ecological Prospect and Planning: Steadily promote the transformation of the future financial landscape

BURN Bank is more than just a blockchain bank, it carries the blueprint for the future of decentralized finance. Its development plan is not only limited to stabilizing the price of BURN tokens, but also covers the exploration of more innovative applications and scenarios. As an open financial ecosystem, BURN aims to continuously expand its application boundaries, meet the financial needs of users around the world, and drive the entire blockchain industry forward.

Stabilize the price and promote the BURN token to become a mainstream asset

The YTL Foundation and the BURN team understand that the price stability of digital assets is the key to driving market confidence and long-term development. Therefore, the primary task of the BURN ecosystem is to ensure the price stability of the BURN token and gradually increase its market value through diversified applications and a reasonable economic model. Through margin mechanism and liquidity management, BURN token can effectively avoid market volatility and provide users with safe and stable financial tools.

In order to further enhance BURN’s market position, the BURN team plans to gradually roll out its token to major exchanges around the world. This move will not only bring broader market liquidity to the BURN token, but will also help it become one of the world’s mainstream digital assets. Through cooperation with the world’s top trading platforms, the BURN token will gradually cover global users and establish partnerships with more financial institutions to promote its application in the international financial market.

Open the blockchain game and NFT market: explore more possibilities of blockchain

In addition to traditional financial functions, the BURN ecosystem will also enter the game-gaming (GameFi) and NFT (non-fungible token) markets to further expand its application scenarios. As an emerging market in the blockchain industry, blockchain games have broad potential and development space. BURN BANK WILL DEVELOP A NUMBER OF BLOCKCHAIN GAME PROJECTS BASED ON ITS STRONG TECHNICAL FOUNDATION, SO THAT USERS CAN NOT ONLY PARTICIPATE IN FINANCIAL TRANSACTIONS, BUT ALSO EARN MONEY THROUGH GAMES. The combination of blockchain games and NFT marketplaces not only injects new vitality into the BURN ecosystem, but also provides users with more diversified ways to participate.

In the NFT field, the BURN ecosystem will launch a number of unique assets based on blockchain technology, such as artworks, collectibles, virtual real estate, etc., to further enrich the application scenarios of BURN. Through these innovative applications, BURN will attract more users and investors to its ecosystem and increase the market demand and value of the BURN token.

Launch of the lending system: Build a comprehensive decentralized financial platform

As the BURN Bank ecosystem continues to expand, its future plans also include the launch of a decentralized lending system. The introduction of the lending system will provide users with more asset management options and help BURN Bank build a comprehensive financial platform. Through decentralized lending, users can use BURN tokens as collateral to obtain liquidity support, so as to meet their funding needs in different scenarios. This system can not only enhance the application value of the BURN token, but also promote the liquidity cycle of the entire ecosystem and enhance its market competitiveness.

Future Prospects: The Global Layout and Vision of the BURN Ecosystem

The YTL Foundation’s collaboration with the BURN team is not just to build a blockchain finance project, but to move the entire industry forward. In the process of global layout, the BURN team has always insisted on paying equal attention to technological innovation and user experience, and is committed to providing a safe, efficient and decentralized financial platform for global users. In the future, the BURN ecosystem will continue to expand its global user base and establish cooperation with blockchain projects, government agencies and financial institutions in various countries to promote the wide application of blockchain technology.

The BURN ecosystem is not just a project, it represents the future of blockchain finance. Through technological innovation, globalization strategy and diversified application scenarios, the BURN ecosystem will surely occupy a place in the future financial field. The strong support and financial strength of the YTL Foundation will provide a steady stream of power for the growth of the BURN ecosystem, help it rise rapidly in the blockchain industry, and become an important force leading the industry change.

conclusion

The construction of the BURN Bank ecosystem is not only an important step for YTL Foundation to step into the blockchain industry, but also a deep thinking and innovative exploration of the future financial model. In this ecosystem, YTL Foundation is shaping a safe, efficient, and creative financial ecosystem by combining its rich experience in the real industry with the cutting-edge application of blockchain technology. In the future, the BURN token will not only be a digital asset, but also an important bridge between traditional finance and decentralized finance.

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

LATEST POST